We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Model Enables Personalized Glucose Predictions for Type 1 Diabetes

By LabMedica International staff writers
Posted on 18 Mar 2026

Type 1 diabetes (T1D) requires careful blood glucose monitoring and precise insulin dosing, as even small errors can lead to dangerous excursions. More...

Continuous glucose monitoring (CGM) provides real-time data for prediction, but physiologic differences between users and limited adaptability for new users remain challenges. Many existing algorithms focus on either short- or long-term patterns, overlooking complementary dynamics and reducing consistency across ages and daily routines. Researchers have now developed a machine-learning model to improve individual glucose forecasting by addressing the patient-to-patient variability that has limited current tools.

Developed at Jeonbuk National University (Jeonju, South Korea), BiT‑MAML combines bidirectional long short‑term memory (LSTM) and Transformer architectures with Model‑Agnostic Meta‑Learning (MAML). The LSTM component processes continuous glucose time series bidirectionally to capture short‑term fluctuations. The Transformer, utilizing a multi‑head attention, models longer‑range, lifestyle‑linked cycles, while meta‑learning accelerates personalization from limited data.

Performance was assessed using leave‑one‑patient‑out cross‑validation, training on multiple patients and testing on an unseen case. Compared with conventional approaches, the model achieved significantly lower prediction errors. Absolute errors ranged from 19.64 to 30.57 milligrams per deciliter across individuals, highlighting gains over standard long short‑term memory baselines and persistent variability.

The work was published in Scientific Reports. The researchers emphasize the importance of evaluation frameworks that transparently capture variability across users. They note that combining advanced architectures with robust assessment can strengthen trust and performance in continuous glucose monitoring–based prediction for people with type 1 diabetes.

"BG dynamics are not uniform across all patients. The physiological patterns of an elderly patient are vastly different from those of a young adult," said Jaehyuk Cho, Professor in the Department of Software Engineering at Jeonbuk National University.

"Addressing this challenge will contribute to the development of effective CGM models that can serve diverse patients with T1D, from children to the elderly," said Jaehyuk Cho, Professor in the Department of Software Engineering at Jeonbuk National University.


New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Chemistry Analyzer
Yumizen C600
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: HBV RNA in blood is as a stronger predictor of liver cancer risk in patients treated for chronic hepatitis B (Photo courtesy of Adobe Stock)

New Biomarkers Indicate Higher Liver Cancer Risk in Chronic Hepatitis B Patients

Chronic hepatitis B affects around 296 million people worldwide and is a major cause of liver cirrhosis and liver cancer. While modern antiviral treatments can suppress the virus and significantly improve... Read more

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.